The US Food and Drug Administration (FDA) has accepted for priority review Otsuka Pharmaceutical’s new drug application (NDA) ...
The current edition of the Diagnostic and Statistical Manual is known as the DSM-5. What will the next version be called?
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
The Trump administration on Tuesday asked a federal court to pause a Louisiana lawsuit seeking to end access to abortion ...
Understanding both sides of this medication is essential before starting or continuing to take it.
Tagatose is not an artificial sweetener, but is a breakdown product of glucose, and is very similar to the sugar galactose, ...
The Department of Health (DOH) and the Food and Drug Administration (FDA) remind the public anew to be more vigilant in ...
Shilpa Biologicals, part of the Shilpa Medicare Group, said the biologic is a first-in-class, immunology-driven therapy ...
Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...
Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will navigate a growing pool of wearables.
The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.
Cytokinetics is committed to supporting patients with MYQORZO & You™, a personalized program for patients prescribed MYQORZO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results